M E Bigal

Summary

Affiliation: Albert Einstein College of Medicine
Country: USA

Publications

  1. ncbi The International Classification of Headache Disorders revised criteria for chronic migraine—field testing in a headache specialty clinic
    M E Bigal
    Department of Neurology, Albert Einstein College of Medicine, 1165 Morris Park Avenue, Bronx, NY 10461, USA
    Cephalalgia 27:230-4. 2007
  2. ncbi Migraine days decline with duration of illness in adolescents with transformed migraine
    M E Bigal
    Department of Neurology, Albert Einstein College of Medicine, New York, NY, USA
    Cephalalgia 25:482-7. 2005
  3. ncbi Obesity is a risk factor for transformed migraine but not chronic tension-type headache
    Marcelo E Bigal
    Department of Neurology, Albert Einstein College of Medicine, Bronx, NY, USA
    Neurology 67:252-7. 2006
  4. ncbi Age-dependent prevalence and clinical features of migraine
    Marcelo E Bigal
    Department of Neurology, Albert Einstein College of Medicine, Bronx, NY, USA
    Neurology 67:246-51. 2006
  5. ncbi The preventive treatment of migraine
    Marcelo E Bigal
    Departments of Neurology, Albert Einstein College of Medicine, Bronx, New York, USA
    Neurologist 12:204-13. 2006
  6. ncbi Epilepsy and migraine
    M E Bigal
    Department of Neurology, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, NY 10461, USA
    Epilepsy Behav 4:S13-24. 2003
  7. ncbi The epidemiology and impact of migraine
    Marcelo E Bigal
    Department of Neurology, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, NY 10461, USA
    Curr Neurol Neurosci Rep 4:98-104. 2004
  8. ncbi Field testing alternative criteria for chronic migraine
    M E Bigal
    Department of Neurology, Albert Einstein College of Medicine, Bronx, NY, USA
    Cephalalgia 26:477-82. 2006
  9. ncbi Headache prevention outcome and body mass index
    M E Bigal
    Department of Neurology, Albert Einstein College of Medicine, Bronx, NY, USA
    Cephalalgia 26:445-50. 2006
  10. ncbi Prophylactic migraine therapy: emerging treatment options
    Marcelo E Bigal
    Department of Neurology, Albert Einstein College of Medicine, 1165 Morris Park Avenue, Bronx, NY 10461, USA
    Curr Pain Headache Rep 8:178-84. 2004

Detail Information

Publications112 found, 100 shown here

  1. ncbi The International Classification of Headache Disorders revised criteria for chronic migraine—field testing in a headache specialty clinic
    M E Bigal
    Department of Neurology, Albert Einstein College of Medicine, 1165 Morris Park Avenue, Bronx, NY 10461, USA
    Cephalalgia 27:230-4. 2007
    ..In the population where use of specific acute migraine medications is less common, the agreement between ICHD-2R CM and TM may be less robust...
  2. ncbi Migraine days decline with duration of illness in adolescents with transformed migraine
    M E Bigal
    Department of Neurology, Albert Einstein College of Medicine, New York, NY, USA
    Cephalalgia 25:482-7. 2005
    ..These findings suggest that early in the process of transformation, migraine is more frequent, and that as CDH evolves, fewer typical attacks of IHS migraine occur...
  3. ncbi Obesity is a risk factor for transformed migraine but not chronic tension-type headache
    Marcelo E Bigal
    Department of Neurology, Albert Einstein College of Medicine, Bronx, NY, USA
    Neurology 67:252-7. 2006
    ..To assess the influence of the body mass index (BMI) on the prevalence and severity of chronic daily headache (CDH) and its most frequent subtypes, transformed migraine (TM) and chronic tension-type headache (CTTH)...
  4. ncbi Age-dependent prevalence and clinical features of migraine
    Marcelo E Bigal
    Department of Neurology, Albert Einstein College of Medicine, Bronx, NY, USA
    Neurology 67:246-51. 2006
    ..Available data suggest two seemingly opposite trends with regard to the natural history of migraine. Migraine prevalence decreases with age. In some individuals, migraine progresses to chronic daily headache...
  5. ncbi The preventive treatment of migraine
    Marcelo E Bigal
    Departments of Neurology, Albert Einstein College of Medicine, Bronx, New York, USA
    Neurologist 12:204-13. 2006
    ..Migraine is a common, chronic, and disabling disorder. The treatment of migraine includes a combination of nonpharmacologic and pharmacologic techniques. Pharmacologic approaches are subdivided in preventive therapies and acute care...
  6. ncbi Epilepsy and migraine
    M E Bigal
    Department of Neurology, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, NY 10461, USA
    Epilepsy Behav 4:S13-24. 2003
    ..We summarize the epidemiologic evidence that migraine and epilepsy are associated and discuss specific interrelationships between migraine and epilepsy...
  7. ncbi The epidemiology and impact of migraine
    Marcelo E Bigal
    Department of Neurology, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, NY 10461, USA
    Curr Neurol Neurosci Rep 4:98-104. 2004
    ..Probable migraine is a prevalent form of migraine, and like migraine with and without aura it produces decrements in health-related quality of life and increments in disability relative to control subjects...
  8. ncbi Field testing alternative criteria for chronic migraine
    M E Bigal
    Department of Neurology, Albert Einstein College of Medicine, Bronx, NY, USA
    Cephalalgia 26:477-82. 2006
    ..Consistently, criteria for CM and CM+ should be revised to require at least 8 days of migraine or probable migraine per month, in individuals with 15 or more days of headache per month...
  9. ncbi Headache prevention outcome and body mass index
    M E Bigal
    Department of Neurology, Albert Einstein College of Medicine, Bronx, NY, USA
    Cephalalgia 26:445-50. 2006
    ..Contrary to what we hypothesized, obesity at baseline does not seem to be related to follow-up refractoriness to preventive treatment...
  10. ncbi Prophylactic migraine therapy: emerging treatment options
    Marcelo E Bigal
    Department of Neurology, Albert Einstein College of Medicine, 1165 Morris Park Avenue, Bronx, NY 10461, USA
    Curr Pain Headache Rep 8:178-84. 2004
    ..Data are presented on topiramate, levetiracetam, zonisamide, botulinim toxin, tizanidine, nefazodone, lisinopril, candesartan, carabersat, petasites, and coenzyme Q...
  11. ncbi Transformed migraine and medication overuse in a tertiary headache centre--clinical characteristics and treatment outcomes
    M E Bigal
    Department of Neurology, Albert Einstein College of Medicine, Bronx, New York, USA
    Cephalalgia 24:483-90. 2004
    ..001). More rigorous prescribing guidelines for patients with frequent headaches are urgently needed. Successful detoxification is necessary to ensure improvement in the headache status when treating patients who overuse acute medications...
  12. ncbi Primary chronic daily headache and its subtypes in adolescents and adults
    M E Bigal
    Department of Neurology, Albert Einstein College of Medicine, 1165 Morris Park Avenue, Bronx, NY 10461, USA
    Neurology 63:843-7. 2004
    ..To determine the relative frequency of chronic daily headache (CDH) subtypes in adolescents and to compare the distribution of CDH subtypes in adolescents and adults of various ages...
  13. ncbi Obesity and migraine: a population study
    Marcelo E Bigal
    Department of Neurology, Albert Einstein College of Medicine, Bronx, NY, USA
    Neurology 66:545-50. 2006
    ..To assess the influence of body mass index (BMI) on the prevalence, attack frequency, and clinical features of migraine...
  14. ncbi Chronic migraine is an earlier stage of transformed migraine in adults
    M E Bigal
    Department of Neurology, Albert Einstein College of Medicine, Bronx, NY, USA
    Neurology 65:1556-61. 2005
    ..They are often classified as transformed migraine (TM), a disorder not addressed in the International Headache Society classification...
  15. ncbi Tension-type headache: classification and diagnosis
    Marcelo E Bigal
    Department of Neurology, Albert Einstein College of Medicine, 1165 Morris Park Avenue, Bronx, NY 10461, USA
    Curr Pain Headache Rep 9:423-9. 2005
    ..A structured approach to the patient and a better comprehension of this variability of presentation should translate into better quality of care and a more specific diagnosis for TTH sufferers...
  16. ncbi When migraine progresses: transformed or chronic migraine
    Marcelo E Bigal
    Department of Neurology, Albert Einstein College of Medicine, Bronx, NY 10461, USA
    Expert Rev Neurother 6:297-306. 2006
    ..The risk factors for migraine progression and the mechanisms for progression will be discussed. This review concludes with the prospects for treating transformed migraine and avoiding migraine progression...
  17. ncbi Obesity and chronic daily headache
    Marcelo E Bigal
    Department of Neurology, Albert Einstein College of Medicine, 1165 Morris Park Avenue, Bronx, NY 10461, USA
    Curr Pain Headache Rep 12:56-61. 2008
    ..We then review the potential pathophysiologic mechanisms to support this relationship. We close by briefly discussing clinical interventions related to obesity and migraine...
  18. ncbi Treatment of comorbidities of chronic daily headache
    Sait Ashina
    Marcelo E Bigal, MD, PhD Department of Neurology and the Montefiore Headache Center, Albert Einstein College of Medicine, 1165 Morris Park Avenue, Rousso Building, Room 330, Bronx, NY 10461, USA
    Curr Treat Options Neurol 10:36-43. 2008
    ..Those with high risk of progression will be more aggressively treated, not just to relieve current pain and disability but to prevent progression. Therefore, treatment will focus on decreasing current burden and preventing future burden...
  19. ncbi Migraine at all ages
    Marcelo E Bigal
    Albert Einstein College of Medicine, Department of Neurology, 1165 Morris Park Avenue, Bronx, NY 10451, USA
    Curr Pain Headache Rep 10:207-13. 2006
    ..Clarifying the influence of age on migraine is of importance for clinical diagnosis and treatment. It also may contain clues to evolving disease biology...
  20. ncbi Body mass index and episodic headaches: a population-based study
    Marcelo E Bigal
    Department of Neurology, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, NY 10461, USA
    Arch Intern Med 167:1964-70. 2007
    ....
  21. pmc The differential diagnosis of chronic daily headaches: an algorithm-based approach
    Marcelo E Bigal
    Department of Neurology, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Rousso Bldg, Room 330, Bronx, NY 10461, USA
    J Headache Pain 8:263-72. 2007
    ..The clinical approach to diagnosing CDH is the scope of this review...
  22. ncbi Migraine in adolescents: association with socioeconomic status and family history
    M E Bigal
    Department of Neurology, Albert Einstein College of Medicine, Bronx, NY 10461, USA
    Neurology 69:16-25. 2007
    ..The influence of socioeconomic status on the prevalence of migraine is unknown in adolescents. Accordingly, we investigated the prevalence of migraine in a large sample of adolescents by sociodemographic features...
  23. ncbi New developments in migraine prophylaxis
    Marcelo E Bigal
    Department of Neurology, Albert Einstein College of Medicine, New York, USA
    Expert Opin Pharmacother 4:433-43. 2003
    ..The aim of this review is to present and discuss the new options for migraine prevention...
  24. ncbi Ergotamine and dihydroergotamine: a review
    Marcelo E Bigal
    The New England Center for Headache, 778 Long Ridge Road, Stamford, CT 06902, USA
    Curr Pain Headache Rep 7:55-62. 2003
    ..In patients with status migrainous and patients with frequent headache recurrence, ergotamine is still probably useful...
  25. ncbi The medical management of migraine
    Marcelo E Bigal
    Department of Neurology, Albert Einstein College of Medicine, Bronx, New York 10461, USA
    Am J Ther 11:130-40. 2004
    ..The clinicians have in their armamentariums an ever-expanding variety of medications. With experience, clinicians can match individual patient needs with the specific characteristics of a drug to optimize therapeutic benefit...
  26. ncbi Obesity, migraine, and chronic migraine: possible mechanisms of interaction
    Marcelo E Bigal
    Department of Neurology, Albert Einstein College of Medicine, Bronx, NY 10461, USA
    Neurology 68:1851-61. 2007
    ..Dysfunction in the orexins pathways seems to be a risk factor for both conditions. Finally, conditions that are comorbid to both states (e.g., depression, sleep apnea) may also make the relationship between both diseases more complex...
  27. doi The prognosis of migraine
    Marcelo E Bigal
    Department of Neurology, Albert Einstein College of Medicine, Bronx, New York, USA
    Curr Opin Neurol 21:301-8. 2008
    ..In many, migraine may have a very benign (complete remission) or relatively benign (partial remission) prognosis. In some, migraine persists and in others, it progresses...
  28. ncbi Prevalence and impact of migraine and probable migraine in a health plan
    N V Patel
    AdvancePCS, Albert Einstein College of Medicine, Bronx, NY 10461, USA
    Neurology 63:1432-8. 2004
    ..A large number of headache sufferers with features of migraine fail to meet criteria for strict migraine (SM; migraine with or without aura) but do meet criteria for probable migraine (PM)...
  29. ncbi Zolmitriptan nasal spray in the acute treatment of cluster headache: a double-blind study
    A M Rapoport
    Department of Neurology, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA
    Neurology 69:821-6. 2007
    ..To evaluate the efficacy and tolerability of zolmitriptan 5 mg and 10 mg nasal spray (ZNS) vs placebo in the acute treatment of cluster headache. Design/..
  30. ncbi Classification of primary headaches
    R B Lipton
    Department of Neurology, Albert Einstein College of Medicine, Bronx, NY 10461 1926, USA
    Neurology 63:427-35. 2004
    ..They conclude by presenting an approach to headache diagnosis based upon these criteria...
  31. ncbi Botulinum toxin A for the treatment of greater occipital neuralgia and trigeminal neuralgia: a case report with pathophysiological considerations
    M Volcy
    The New England Centre for Headache, Stamford, CT 06902 1251, USA
    Cephalalgia 26:336-40. 2006
  32. ncbi Familial risk of migraine: variation by proband age at onset and headache severity
    W F Stewart
    Center for Health Research and Rural Advocacy, Geisinger Health System, Baltimore, MD, USA
    Neurology 66:344-8. 2006
    ..It is well established that migraine aggregates within families. Less is known about the influence of proband characteristics (e.g., age at onset, headache severity) on familial aggregation...
  33. ncbi Clinical trials of acute treatments for migraine including multiple attack studies of pain, disability, and health-related quality of life
    R B Lipton
    Department of Neurology, Albert Einstein College of Medicine, Bronx, NY 10461, USA
    Neurology 65:S50-8. 2005
    ..We consider clinical trials strategies designed to address the more complex clinical and policy requirements for meeting the needs of those with migraine...
  34. ncbi Migraine preventive therapy: current and emerging treatment options
    A M Rapoport
    The New England Center for Headache, 778 Long Ridge Road, Stamford, CT 06902 1251, USA
    Neurol Sci 26:s111-20. 2005
    ..In this paper we review new treatment options for migraine prevention. We start with an overview about migraine and then briefly discuss current indications for migraine prevention and new and emerging preventive medications...
  35. ncbi Patterns of health care utilization for migraine in England and in the United States
    R B Lipton
    Department of Neurology, Albert Einstein College of Medicine, Bronx, NY 10461, USA
    Neurology 60:441-8. 2003
    ..To assess patterns of medical consultation, diagnosis, and medication use in representative samples of adults with migraine in England and the United States...
  36. pmc Prevalence and characteristics of allodynia in headache sufferers: a population study
    M E Bigal
    Departments of Neurology, Albert Einstein College of Medicine, Bronx, NY, USA
    Neurology 70:1525-33. 2008
    ..The authors estimated the prevalence and severity of cutaneous allodynia (CA) in individuals with primary headaches from the general population...
  37. ncbi The family impact of migraine: population-based studies in the USA and UK
    R B Lipton
    Department of Neurology, Albert Einstein College of Medicine, Bronx, NY 10461, USA
    Cephalalgia 23:429-40. 2003
    ..02), with their level or responsibilities and duties (P = 0.02), and with their ability to perform (P = 0.001). Results from this study show that the impact of migraine extends to household partners and other family members...
  38. ncbi Chronic daily headache in a tertiary care population: correlation between the International Headache Society diagnostic criteria and proposed revisions of criteria for chronic daily headache
    M E Bigal
    Department of Neurology, Albert Einstein College of Medicine, USA
    Cephalalgia 22:432-8. 2002
    ..The Silberstein and Lipton system is easier to apply, and more parsimonious. These findings support revision of the IHS classification system to include chronic migraine...
  39. ncbi Acetaminophen in the treatment of headaches associated with dipyridamole-aspirin combination
    R B Lipton
    Department of Neurology, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, NY 10461, USA
    Neurology 63:1099-101. 2004
    ..The headaches were self-limited (69.4% placebo efficacy in 2 hours) and the incidence markedly declined over time. Acetaminophen was no more effective than placebo in the acute and preemptive treatment of these headaches...
  40. ncbi Migraine prevalence, disease burden, and the need for preventive therapy
    R B Lipton
    Department of Neurology, The Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, NY 10461, USA
    Neurology 68:343-9. 2007
    ....
  41. doi New daily persistent headache in the paediatric population
    E Kung
    Department of Neurology, Albert Einstein College of Medicine, Bronx, NY, USA
    Cephalalgia 29:17-22. 2009
    ..On most days, they had migraine-associated symptoms (one of nausea, photophobia or phonophobia)). NDPH is common in children and adolescents with CDH. Most subjects do not overuse medication. Migraine features are common...
  42. ncbi MMPI personality profiles in patients with primary chronic daily headache: a case-control study
    M E Bigal
    Department of Neurology, Albert Einstein College of Medicine, Rousso Building, 1165 Morris Park Avenue, Bronx, NY 10461, USA
    Neurol Sci 24:103-10. 2003
    ....
  43. ncbi Persistent idiopathic facial pain responsive to topiramate
    M Volcy
    The New England Center for Headache, Stamford, CT 06902, USA
    Cephalalgia 26:489-91. 2006
  44. ncbi Patterns of medical diagnosis and treatment of migraine and probable migraine in a health plan
    M E Bigal
    Department of Neurology, Albert Einstein College of Medicine, Bronx, New York, NY, USA
    Cephalalgia 26:43-9. 2006
    ..Educational strategies should focus on physician education addressing diagnosing the full spectrum of migraine and physician management of migraine with specific migraine therapy in appropriate patients...
  45. ncbi Why headache treatment fails
    R B Lipton
    Department of Neurology, Albert Einstein College of Medicine, Bronx, NY10461, USA
    Neurology 60:1064-70. 2003
    ..Persistence in treating these patients can be very rewarding. The authors provide a checklist intended to facilitate the management of refractory patients...
  46. ncbi Post-traumatic headache: emphasis on chronic types following mild closed head injury
    F D Sheftell
    New England Center for Headache, 778 Long Ridge Road, Stamford, CT 06902, USA
    Neurol Sci 28:S203-7. 2007
    ..This is perhaps as it should be given that the best practice combines knowledge of the evidence with individual clinical experience...
  47. ncbi Migraine headache disability and health-related quality-of-life: a population-based case-control study from England
    R B Lipton
    Department of Neurology, Albert Einstein College of Medicine, Bronx, New York, NY 10461, USA
    Cephalalgia 23:441-50. 2003
    ..Specifically, individuals classified with moderate to severe work-related disability had lower HRQoL scores than those classified with low disability...
  48. ncbi Double-blind clinical trials of oral triptans vs other classes of acute migraine medication - a review
    R B Lipton
    Department of Neurology, Albert Einstein College of Medicine, Bronx, New York 10461, USA
    Cephalalgia 24:321-32. 2004
    ....
  49. ncbi Short-lasting unilateral neuralgiform headache attacks with cranial autonomic symptoms (SUNA)--a case report
    M Volcy
    The New England Center for Headache, Stamford, CT 06902, USA
    Cephalalgia 25:470-2. 2005
  50. ncbi Migraine practice patterns among neurologists
    R B Lipton
    Department of Neurology, Albert Einstein College of Medicine, Bronx, NY 10461, USA
    Neurology 62:1926-31. 2004
    ..To assess the attitudes, knowledge, and practice patterns of US neurologists regarding migraine management relative to the US Headache Consortium Guidelines (the Guidelines)...
  51. doi Weight change and clinical markers of cardiovascular disease risk during preventive treatment of migraine
    M E Bigal
    Department of Neurology, Albert Einstein College of Medicine, Bronx, NY, USA
    Cephalalgia 29:1188-96. 2009
    ..0 vs. -1.3 mmHg) and high-density lipoprotein cholesterol (-3.7 vs. -0.8 mg/dl). Increased weight during migraine treatment is not associated with poor headache treatment outcomes, but is associated with deterioration of CVD risk markers...
  52. pmc Migraine and cardiovascular disease: possible mechanisms of interaction
    M E Bigal
    Department of Neurology, Albert Einstein College of Medicine, Bronx, NY, USA
    Neurology 72:1864-71. 2009
    ..Ultimately, it will be important to determine whether MA is a modifiable risk factor for CVD and if preventive medications for migraine or antiplatelet therapy might reduce the risk of CVD in patients with MA...
  53. doi Chronic migraine and medication overuse headache: clarifying the current International Headache Society classification criteria
    C Sun-Edelstein
    The New York Headache Center, New York, NY 10021, USA
    Cephalalgia 29:445-52. 2009
    ..We aimed to explain the nature of the controversies surrounding the entities of CM and MOH. A clinical case will be used to illustrate some of the problems faced by clinicians in diagnosing patients with chronic daily headache...
  54. ncbi Which triptan for which patient?
    A M Rapoport
    Department of Neurology, Columbia University, New York, NY, USA
    Neurol Sci 27:S123-9. 2006
    ..New studies have looked at early treatment paradigms and result in better efficacy data, but are difficult to compare due to different endpoints...
  55. ncbi Migraine and adiponectin: is there a connection?
    B L Peterlin
    Department of Neurology, Drexel University College of Medicine, Philadelphia, PA 19102, USA
    Cephalalgia 27:435-46. 2007
    ..Future research may focus on how adiponectin levels are potentially altered during migraine attacks, and how that information can be potentially translated into migraine therapy...
  56. doi Validity and reliability of the Migraine-Treatment Optimization Questionnaire
    R B Lipton
    Department of Neurology, Albert Einstein College of Medicine, New York, NY 10461, USA
    Cephalalgia 29:751-9. 2009
    ..66, and it also correlated well with the three questionnaires (r = 0.33-0.41). The utility of the M-TOQ for assessing treatment benefit in research (M-TOQ-15) and primary care (M-TOQ-5) should be further validated...
  57. pmc Cutaneous allodynia in the migraine population
    Richard B Lipton
    Department of Neurology, Albert Einstein College of Medicine, Bronx, NY 10461, USA
    Ann Neurol 63:148-58. 2008
    ..To develop and validate a questionnaire for assessing cutaneous allodynia (CA), and to estimate the prevalence and severity of CA in the migraine population...
  58. pmc Chronic disorders with episodic manifestations: focus on epilepsy and migraine
    Sheryl R Haut
    Comprehensive Epilepsy Management Center, Montefiore Medical Center and the Albert Einstein College of Medicine, Bronx, NY 10467 2490, USA
    Lancet Neurol 5:148-57. 2006
    ..This investigation draws attention to unique aspects of both epilepsy and migraine, while identifying areas of crossover in which each specialty could benefit from the experience of the other...
  59. ncbi The triptan formulations: a critical evaluation
    Marcelo E Bigal
    Department of Neurology, Albert Einstein College of Medicine, Bronx, NY, USA
    Arq Neuropsiquiatr 61:313-20. 2003
    ....
  60. pmc Chronic pain and obesity in elderly people: results from the Einstein aging study
    Lucas H McCarthy
    Department of Neurology, Albert Einstein College of Medicine, Bronx, New York, USA
    J Am Geriatr Soc 57:115-9. 2009
    ..To determine the prevalence of chronic pain in elderly people and its relationship with obesity and associated comorbidities and risk factors...
  61. ncbi Headache: triumphs in translational research
    Richard B Lipton
    Department of Neurology, Albert Einstein College of Medicine, Bronx, NY, USA
    Lancet Neurol 4:11-2. 2005
  62. ncbi The epidemiology of migraine
    Richard B Lipton
    Department of Neurology, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, New York 10461, USA
    Am J Med 118:3S-10S. 2005
    ..However, prevalence is high in groups other than these high-risk groups. In a subgroup of patients, migraine may be a progressive disorder...
  63. ncbi Hemicrania continua: comparison between two different classification systems
    M E Bigal
    The New England Center for Headache, Stamford, Connecticut, USA
    Cephalalgia 22:242-5. 2002
    ..the Goadsby and Lipton classification is more clinically useful and should be included in future International Headache Society reclassification...
  64. ncbi Migraine: barriers for care
    F D Sheftell
    The New England Center for Headache, 778 Long Ridge Road, Stamford, CT, USA
    Neurol Sci 26:s140-2. 2005
    ....
  65. pmc Occipital levels of GABA are related to severe headaches in migraine
    M E Bigal
    Departments of Neurology, Albert Einstein College of Medicine, Bronx, NY, USA
    Neurology 70:2078-80. 2008
  66. ncbi The patent foramen ovale-migraine question
    S J Tepper
    The New England Center for Headache, 778 Long Ridge Road, Stamford, CT 06902, USA
    Neurol Sci 28:S118-23. 2007
    ..One reported secondary endpoint showed a significant 42% reduction of migraine days, suggesting the need for further randomised, sham-controlled PFO closure studies...
  67. ncbi Ten lessons on the epidemiology of migraine
    Richard B Lipton
    Montefiore Headache Unit, Department of Neurology, Albert Einstein College of Medicine, Bronx, NY 10461, USA
    Headache 47:S2-9. 2007
    ....
  68. doi Clinical course in migraine: conceptualizing migraine transformation
    Marcelo E Bigal
    Department of Neurology, Albert Einstein College of Medicine, Bronx, NY, USA
    Neurology 71:848-55. 2008
    ..Herein we discuss the evidence that migraine may transform and then consider potential mechanisms as well as risk factors. We close with a brief discussion of clinical strategies that arise based on this perspective on migraine...
  69. ncbi Migraine: epidemiology, impact, and risk factors for progression
    Richard B Lipton
    Department of Neurology, Albert Einstein College of Medicine and Montefiore Headache Unit, Bronx, NY 10461, USA
    Headache 45:S3-S13. 2005
    ..Future epidemiologic studies should focus on identifying patients who are at higher risk for progression and on assessing the impact of intervention strategies on disease progression...
  70. ncbi Intranasal medications for the treatment of migraine and cluster headache
    Alan M Rapoport
    Columbia University College of Physicians and Surgeons, New York, NY, USA
    CNS Drugs 18:671-85. 2004
    ..Nevertheless, it is our opinion that nasal preparations increase therapeutic options and may result in faster response times and better efficacy than oral formulations and better patient satisfaction than injectable preparations...
  71. ncbi Hemicrania continua: clinical and nosographic update
    A M Rapoport
    Department of Neurology, Columbia University College of Physicians and Surgeons, New York, NY, USA
    Neurol Sci 24:S118-21. 2003
    ..HC will be addressed in the 2003 revision of the International Headache Society (IHS). In this paper we review the clinical features, classification and treatment of HC...
  72. ncbi Intravenous dipyrone for the acute treatment of episodic tension-type headache: a randomized, placebo-controlled, double-blind study
    M E Bigal
    Departmet of Neurology, Albert Einstein School of Medicine, Bronx, NY, USA
    Braz J Med Biol Res 35:1139-45. 2002
    ..6%) for the dipyrone group. Intravenous dipyrone is an effective drug for the relief of pain in tension-type headache and its use is justified in the emergency room setting...
  73. ncbi Cluster headache as a manifestation of intracranial inflammatory myofibroblastic tumour: a case report with pathophysiological considerations
    M E Bigal
    Department of Neurology, Albert Einstein College of Medicine and The New England Center for Headache, Stamford, CT 06902, USA
    Cephalalgia 23:124-8. 2003
    ....
  74. ncbi The clinical spectrum of migraine
    Alan M Rapoport
    Columbia University College of Physicians and Surgeons, New York, NY, USA
    Compr Ther 29:35-42. 2003
    ..A structured approach to the patient and a better comprehension of this variability of presentation, should translate into better quality of care for migraineurs...
  75. ncbi Chronic daily headache: identification of factors associated with induction and transformation
    Marcelo E Bigal
    Department of Neurology and Epidemiology, Albert Einstein College of Medicine, Bronx, New York, USA
    Headache 42:575-81. 2002
    ..The analysis of factors related to the transformation from episodic to chronic migraine (CM) and to the de novo development of new daily persistent headache (NDPH) remain poorly understood...
  76. doi Looking to the future: research designs for study of headache disease progression
    Richard B Lipton
    Department of Neurology, Albert Einstein College of Medicine, Bronx, New York 10461, USA
    Headache 48:58-66. 2008
    ....
  77. ncbi Assessment of migraine disability using the migraine disability assessment (MIDAS) questionnaire: a comparison of chronic migraine with episodic migraine
    Marcelo E Bigal
    Department of Neurology, Albert Einstein College of Medicine, Office 334 A, Rousso Building, 1165 Morris Park Avenue, Bronx, NY 10461, USA
    Headache 43:336-42. 2003
    ..Chronic migraine is the most common type of chronic daily headache seen in headache tertiary care centers. Most patients with chronic migraine report their ability to function and feeling of well-being as severely impaired...
  78. ncbi The triptan formulations : how to match patients and products
    Alan M Rapoport
    Department of Neurology, College of Physicians and Surgeons, Columbia University, New York, New York, USA
    CNS Drugs 17:431-47. 2003
    ..Use of the methods outlined in this review in choosing a triptan for an individual patient is probably more likely to lead to migraine relief than making an educated guess as to which triptan is most appropriate...
  79. doi Concepts and mechanisms of migraine chronification
    Marcelo E Bigal
    Department of Neurology, Albert Einstein College of Medicine, Bronx, NY, USA
    Headache 48:7-15. 2008
    ..Research on this issue is in its infancy and cautions are necessary before extrapolating this information into clinical practice...
  80. ncbi Intravenous dipyrone in the acute treatment of migraine without aura and migraine with aura: a randomized, double blind, placebo controlled study
    Marcelo E Bigal
    Department of Neurology, Albert Einstein College of Medicine, Bronx, New York, USA
    Headache 42:862-71. 2002
    ..Dipyrone (Metamizol) has been used in the acute treatment of migraines in Brazil. Some investigators have found it to be a highly effective medication for migraine pain and associated symptoms...
  81. doi Toward an epidemiology of refractory migraine: current knowledge and issues for future research
    Richard B Lipton
    Departments of Neurology and Epidemiology and Population Health, Albert Einstein College of Medicine, and The Montefiore Headache Center, Bronx, NY, USA
    Headache 48:791-8. 2008
    ..The epidemiology of these modifiers is discussed...
  82. ncbi Migraine with aura versus migraine without aura: pain intensity and associated symptom intensities after placebo
    Marcelo E Bigal
    Department of Neurology, Albert Einstein College of Medicine, Bronx, New York, USA
    Headache 42:872-7. 2002
    ..To compare the intensity of pain and associated symptoms after placebo administration in patients with migraine with aura and migraine without aura...
  83. doi Headache as a real disease
    Richard B Lipton
    Albert Einstein College of Medicine, Bronx, New York, USA
    Headache 48:707-10. 2008
    ..Drs. Lipton and Bigal examine the path to acceptance and the impediments that had to be overcome...
  84. ncbi Botulinum neurotoxin type A in the preventive treatment of refractory headache: a review of 100 consecutive cases
    Stewart J Tepper
    The New England Center for Headache, Stamford, CT 06902, USA
    Headache 44:794-800. 2004
    ..To review the efficacy of botulinum neurotoxin type A (BoNT-A) in the preventive treatment of refractory headache...
  85. ncbi Patterns of use of triptans and reasons for switching them in a tertiary care migraine population
    Fred D Sheftell
    Department of Psychiatry, New York Medical College, NY, USA
    Headache 44:661-8. 2004
    ..To assess the reasons for switching triptans within migraine patients presenting to a specialty clinic...
  86. ncbi Modifiable risk factors for migraine progression (or for chronic daily headaches)--clinical lessons
    Marcelo E Bigal
    Department of Neurology, Albert Einstein College of Medicine, Bronx, NY 10461, USA
    Headache 46:S144-6. 2006
    ..These recommendations have not been demonstrated to improve outcomes in longitudinal studies...
  87. ncbi Zolmitriptan (Zomig)
    Alan M Rapoport
    College of Physicians and Surgeons, Columbia University, New York, NY, USA
    Expert Rev Neurother 4:33-41. 2004
    ..5-mg dose at early time points. The physician can now choose the optimum route of delivery of zolmitriptan to stop the headache, increase the likelihood of reducing disability and restore the patient to complete functionality...
  88. ncbi Tools for diagnosing migraine and measuring its severity
    Richard B Lipton
    Department of Neurology, The Albert Einstein College of Medicine, Bronx, NY, USA
    Headache 44:387-98. 2004
    ..Migraine is assessed to determine how well it meets criteria for screening and the steps that are necessary before firm public policy recommendations for screening for migraine are possible...
  89. ncbi ID-migraine
    A M Rapoport
    Department of Neurology, Columbia University College of Physicians and Surgeons, New York, NY, USA
    Neurol Sci 25:S258-60. 2004
    ..Herein we briefly discuss reasons for screening migraine in the primary care setting, and focus on the ID-migraine, a validated migraine screening tool...
  90. ncbi Preventive migraine therapy: what is new
    A M Rapoport
    Department of Neurology, Columbia University College of Physicians and Surgeons, New York, NY, USA
    Neurol Sci 25:S177-85. 2004
    ....
  91. ncbi Surgical treatment of patients with refractory migraine headaches and intranasal contact points
    F Behin
    Mount Sinai Medical Center, New York, NY, USA
    Cephalalgia 25:439-43. 2005
    ..Prospective studies are necessary to confirm our results...
  92. ncbi Tinnitus in migraine: an allodynic symptom secondary to abnormal cortical functioning?
    Michel Volcy
    The New England Center for Headache, Stanford, Connecticut 06902, USA
    Headache 45:1083-7. 2005
    ..We hypothesize that the tinnitus intensity increase could be an allodynic symptom related to CS, or alternatively could be associated with cortical hyperexcitability...
  93. ncbi Assessment of adverse events associated with triptans--methods of assessment influence the results
    Fred D Sheftell
    New York Medical College, Psychiatry, New York, NY, USA
    Headache 44:978-82. 2004
    ..However, the proportion of patients reporting side effects after any acute treatment may vary with regard to the method of assessment...
  94. ncbi The classification of chronic daily headache in adolescents--a comparison between the second edition of the international classification of headache disorders and alternative diagnostic criteria
    Marcelo E Bigal
    Albert Einstein College of Medicine, Neurology, Bronx, NY, USA
    Headache 45:582-9. 2005
    ..To compare the second edition of the International Classification of Headache Disorders (ICHD-2) and the Silberstein-Lipton (S-L) criteria in the classification of adolescents with chronic daily headache (CDH)...
  95. ncbi Multiple cranial neuropathies, headache, and facial pain in a septuagenarian
    Brian M Grosberg
    Albert Einstein College of Medicine, The Montefiore Headache Unit, Bronx, NY, USA
    Headache 44:1038-9. 2004
  96. ncbi Hemicrania continua: a report of ten new cases
    Marcelo E Bigal
    International Headache Society Fellow, The New England Center for Headache, New York, NY, USA
    Arq Neuropsiquiatr 60:695-8. 2002
    ..Although the cardinal features of HC - continuous, unilateral, indomethacin responsive, remain strongly reliable, a refinement on the clinical characterization is needful and desired...
  97. ncbi New onset headache in a woman with recurrent ear infections
    Brian M Grosberg
    Montefiore Headache Unit, Albert Einstein College of Medicine, Bronx, NY, USA
    Headache 45:240-1. 2005
  98. ncbi Naratriptan in the preventive treatment of refractory chronic migraine: a review of 27 cases
    Alan M Rapoport
    Department of Neurology, Columbia University College of Physicians and Surgeons, New York, NY, USA
    Headache 43:482-9. 2003
    ..To review the efficacy of naratriptan as preventive treatment in 27 patients with chronic migraine refractory to other commonly used preventive therapies...
  99. ncbi Naratriptan in the preventive treatment of refractory transformed migraine: a prospective pilot study
    Fred D Sheftell
    The New England Center for Headache, College of Medicine, Stanford, CT, USA
    Headache 45:1400-6. 2005
    ..To assess the efficacy, safety, and tolerability of daily naratriptan in the preventive treatment of transformed migraine (TM) refractory to previous first line therapies...
  100. ncbi Chronic daily headache: correlation between the 2004 and the 1988 International Headache Society diagnostic criteria
    Marcelo E Bigal
    Department of Neurology, Albert Einstein College of Medicine
    Headache 44:684-91. 2004
    ..Both systems allowed for the classification of most patients with CDH. The 1988 IHS classification required multiple diagnoses and was more complex to apply...
  101. ncbi Modifiable risk factors for migraine progression
    Marcelo E Bigal
    Department of Neurology, Albert Einstein College of Medicine, Bronx, NY 10461, USA
    Headache 46:1334-43. 2006
    ..We present the evidence for each risk factor and discuss possible interventions to address them...